GlassScriptPhysician profile
Kaitlyn Alyssa Trantham
NPI 1922596790
$1,247.96
in general payments reported to CMS, 2019-2025
16 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.80 · 2020: $15.29 · 2021: $216 · 2022: $103 · 2023: $295 · 2024: $379 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $261.94 | 2020-2025 | Ozempic, Rybelsus, Tresiba |
| Abbvie INC. | $212.32 | 2021-2025 | |
| Lilly USA, LLC | $174.07 | 2023-2025 | Mounjaro |
| Dexcom, INC. | $168.74 | 2023-2024 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $104.96 | 2021 | |
| Sumitomo Pharma America, INC. | $60.55 | 2024 | Gemtesa |
| Medtronic, INC. | $51.49 | 2025 | Intellis Adaptivestim |
| Novartis Pharmaceuticals Corporation | $36.99 | 2024 | |
| Amgen INC. | $35.62 | 2024 | Otezla, Repatha |
| Astellas Pharma US INC | $33.86 | 2023 | Veozah |
| Exact Sciences Corporation | $32.39 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Daiichi Sankyo INC. | $20.29 | 2024 | Injectafer |
| Astrazeneca Pharmaceuticals LP | $16.97 | 2024 | Farxiga |
| Shield Therapeutics INC | $13.18 | 2024 | |
| Gt Medical Technologies, INC | $12.79 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlyn Trantham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.